SAB Biotherapeutics (SABS)
US Market

SAB Biotherapeutics (SABS) Stock Price & Analysis


SABS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.37 - $1.81
Previous Close$0.96
Average Volume (3M)1.36M
Market Cap
Enterprise Value$40.78M
Total Cash (Recent Filing)$13.06M
Total Debt (Recent Filing)$5.46M
Price to Earnings (P/E)-1.7
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding50,394,262
10 Day Avg. Volume53,681
30 Day Avg. Volume1,360,313
Standard Deviation0.35
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)82.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue70.18
Enterprise Value/Gross Profit1.71
Enterprise Value/Ebitda-1.75
Price Target Upside264.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was SAB Biotherapeutics’s price range in the past 12 months?
SAB Biotherapeutics lowest stock price was $0.36 and its highest was $1.81 in the past 12 months.
    What is SAB Biotherapeutics’s market cap?
    Currently, no data Available
    When is SAB Biotherapeutics’s upcoming earnings report date?
    SAB Biotherapeutics’s upcoming earnings report date is Aug 09, 2023 which is in 62 days.
      How were SAB Biotherapeutics’s earnings last quarter?
      Currently, no data Available
      Is SAB Biotherapeutics overvalued?
      According to Wall Street analysts SAB Biotherapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does SAB Biotherapeutics pay dividends?
        SAB Biotherapeutics does not currently pay dividends.
        What is SAB Biotherapeutics’s EPS estimate?
        SAB Biotherapeutics’s EPS estimate is -$0.14.
          How many shares outstanding does SAB Biotherapeutics have?
          SAB Biotherapeutics has 50,397,762 shares outstanding.
            What happened to SAB Biotherapeutics’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of SAB Biotherapeutics?
            Among the largest hedge funds holding SAB Biotherapeutics’s share is Fir Tree Inc.. It holds SAB Biotherapeutics’s shares valued at 4M.


              SAB Biotherapeutics Stock Smart Score

              The SAB Biotherapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              SAB Biotherapeutics

              Blue Calypso Inc is engaged in the development, sales, delivery and licensing of technology and intellectual property focused on mobile shopper engagement, digital word of mouth and location-based marketing and advertising. Its solutions include mobile engagement, POP and merchandise tracking, mobile plant tag engagement. The company derives its revenues from the cloud-based consumption of its technology platform, consulting fees and licensing of its technologies.


              Top 5 ETFs holding SABS

              Currently, no data available
              Please return soon. This page is being updated.
              Up to five ETFs with an Outperform Smart Score that hold SABS. The ETFs are listed according to market value of SABS within the ETF


              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Price & Change
              SELLAS Life Sciences Group
              Galera Therapeutics
              MEI Pharma
              Biora Therapeutics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis